Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
38.46
Dollar change
-1.46
Percentage change
-3.66
%
Feb 06, 5:51 PMCentene posts a narrower‑than‑expected Q4 adjusted loss on better‑than‑forecast revenue and says it completed the Magellan Health asset divestiture in December with a $389M after‑tax impairment; it raised 2025 adjusted EPS guidance to $2.08 and set 2025 revenue at $186.5–$190.5B. On its Q4 call, Centene targeted 2026 adjusted EPS above $3 on $170–$174B revenue (HBR ~91%, assuming a 4.5% Medicaid rate increase) and said 2026 earnings will be highly seasonal with most EPS in Q1 and an expected Q4 loss amid Medicaid and Marketplace margin recovery.
IndexS&P 500 P/E- EPS (ttm)-13.62 Insider Own2.73% Shs Outstand491.76M Perf Week-11.22%
Market Cap18.90B Forward P/E9.05 EPS next Y4.25 Insider Trans-0.35% Shs Float478.11M Perf Month-15.97%
Enterprise Value- PEG0.19 EPS next Q2.23 Inst Own95.19% Short Float2.56% Perf Quarter4.40%
Income-6.67B P/S0.10 EPS this Y44.76% Inst Trans-2.88% Short Ratio1.74 Perf Half Y52.26%
Sales194.78B P/B0.95 EPS next Y41.14% ROA-8.33% Short Interest12.23M Perf YTD-6.54%
Book/sh40.57 P/C- EPS next 5Y46.48% ROE-28.79% 52W High66.03 -41.75% Perf Year-36.67%
Cash/sh- P/FCF4.37 EPS past 3/5Y- - ROIC-17.89% 52W Low25.08 53.38% Perf 3Y-48.82%
Dividend Est.- EV/EBITDA- Sales past 3/5Y10.45% 11.88% Gross Margin- Volatility4.83% 3.95% Perf 5Y-35.47%
Dividend TTM- EV/Sales- EPS Y/Y TTM-317.13% Oper. Margin-0.15% ATR (14)1.77 Perf 10Y23.94%
Dividend Ex-Date- Quick Ratio- Sales Y/Y TTM19.44% Profit Margin-3.43% RSI (14)32.43 Recom2.58
Dividend Gr. 3/5Y- - Current Ratio1.10 EPS Q/Q-497.29% SMA20-12.77% Beta0.51 Target Price44.27
Payout0.00% Debt/Eq0.87 Sales Q/Q21.86% SMA50-8.14% Rel Volume2.36 Prev Close39.92
Employees60500 LT Debt/Eq0.87 EarningsFeb 06 BMO SMA200-5.57% Avg Volume7.03M Price38.46
IPODec 13, 2001 Option/ShortYes / Yes EPS/Sales Surpr.2.55% 2.77% Trades Volume16,602,653 Change-3.66%
Date Action Analyst Rating Change Price Target Change
Jan-05-26Upgrade Barclays Equal Weight → Overweight $54
Oct-14-25Initiated Goldman Sell $33
Jul-28-25Downgrade Cantor Fitzgerald Overweight → Neutral $38
Jul-23-25Downgrade Wells Fargo Overweight → Equal Weight $30
Jul-21-25Downgrade TD Cowen Buy → Hold $33
Jul-16-25Downgrade BofA Securities Neutral → Underperform $30
Jul-10-25Downgrade Morgan Stanley Overweight → Equal-Weight $33
Jul-02-25Downgrade UBS Buy → Neutral $45
Jul-02-25Downgrade JP Morgan Overweight → Neutral $48
Jun-09-25Resumed Morgan Stanley Overweight $70
Feb-06-26 05:33PM
04:28PM
04:01PM
01:49PM
01:23PM
12:35PM Loading…
12:35PM
11:58AM
11:17AM
11:00AM
10:45AM
09:30AM
07:25AM
07:13AM
06:56AM
06:56AM
06:34AM Loading…
06:34AM
06:00AM
Feb-05-26 10:59AM
10:32AM
07:10AM
Feb-04-26 10:02PM
09:41PM
06:46AM
Feb-03-26 12:36PM
03:08AM
Feb-02-26 08:54AM
08:29AM
Feb-01-26 07:47AM
Jan-31-26 07:38AM
Jan-29-26 08:30AM
02:19AM Loading…
02:19AM
Jan-28-26 12:03PM
10:31AM
08:01AM
Jan-27-26 04:44PM
04:44PM
04:34PM
04:13PM
12:55PM
12:20PM
11:15AM
10:39AM
10:35AM
10:07AM
09:55AM
08:52AM
07:17AM
07:16AM
07:15AM
03:18AM
Jan-26-26 11:35PM
10:16PM
10:16PM
Jan-22-26 08:00AM
Jan-21-26 01:29PM
Jan-20-26 09:48AM
Jan-19-26 09:33AM
07:38AM
Jan-16-26 10:47AM
Jan-15-26 03:10PM
12:04PM
08:00AM
Jan-13-26 04:30PM
05:30AM
Jan-08-26 12:21PM
Jan-07-26 08:00AM
Jan-06-26 11:04AM
07:04AM
Jan-05-26 12:16PM
11:08AM
07:15AM
Jan-01-26 11:05PM
Dec-30-25 10:16AM
Dec-29-25 08:12PM
Dec-23-25 09:08AM
Dec-22-25 11:33PM
Dec-19-25 08:45AM
Dec-17-25 03:01PM
01:00PM
10:56AM
09:10AM
07:11AM
07:11AM
Dec-16-25 04:01PM
02:10PM
03:56AM
Dec-15-25 12:35PM
Dec-12-25 03:22PM
Dec-11-25 11:35PM
03:00PM
01:08PM
11:41AM
Dec-09-25 11:33PM
Dec-04-25 07:37AM
Dec-03-25 07:51AM
Dec-02-25 09:39AM
Nov-28-25 05:30PM
11:30AM
08:50AM
Nov-26-25 11:00AM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burdick Kenneth ADirectorDec 03 '25Sale39.0433,2111,296,557305,161Dec 05 05:06 PM
Burdick Kenneth ADirectorDec 04 '25Sale39.0032,7961,279,044272,365Dec 05 05:06 PM
Burdick Kenneth ADirectorDec 04 '25Proposed Sale39.0032,7961,279,044Dec 04 04:39 PM
Burdick Kenneth ADirectorDec 03 '25Proposed Sale39.0433,2111,296,621Dec 03 04:59 PM
Wayne S DeVeydtDirectorOct 15 '25Proposed Sale35.845,489196,737Oct 15 03:29 PM
DeVeydt Wayne SDirectorSep 09 '25Proposed Sale29.1910,775314,545Sep 09 01:55 PM
LONDON SARAHChief Executive OfficerAug 08 '25Buy25.5019,230490,365845,275Aug 11 05:28 PM
Samuels Theodore R. IIDirectorJul 28 '25Buy27.629,000248,58032,000Jul 29 06:01 PM
FASOLA KENNETH JOfficerMar 21 '25Proposed Sale59.068,500501,970Mar 21 10:37 AM
Last Close
Feb 06  •  04:00PM ET
6.83
Dollar change
+0.29
Percentage change
4.43
%
LFST LifeStance Health Group Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.02 Insider Own58.81% Shs Outstand389.00M Perf Week-3.39%
Market Cap2.66B Forward P/E148.41 EPS next Y0.05 Insider Trans-8.27% Shs Float160.23M Perf Month-6.44%
Enterprise Value2.93B PEG- EPS next Q-0.00 Inst Own40.84% Short Float4.99% Perf Quarter42.00%
Income-9.12M P/S1.94 EPS this Y97.11% Inst Trans-2.29% Short Ratio3.72 Perf Half Y76.94%
Sales1.37B P/B1.78 EPS next Y1161.74% ROA-0.43% Short Interest7.99M Perf YTD-2.98%
Book/sh3.84 P/C13.03 EPS next 5Y- ROE-0.62% 52W High8.30 -17.66% Perf Year-16.20%
Cash/sh0.52 P/FCF22.25 EPS past 3/5Y47.55% 0.80% ROIC-0.48% 52W Low3.74 82.62% Perf 3Y26.72%
Dividend Est.- EV/EBITDA45.42 Sales past 3/5Y23.29% 42.55% Gross Margin28.39% Volatility5.17% 3.58% Perf 5Y-
Dividend TTM- EV/Sales2.14 EPS Y/Y TTM90.55% Oper. Margin0.62% ATR (14)0.26 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.58 Sales Y/Y TTM13.39% Profit Margin-0.67% RSI (14)43.03 Recom1.30
Dividend Gr. 3/5Y- - Current Ratio1.58 EPS Q/Q117.83% SMA20-4.74% Beta1.12 Target Price9.00
Payout- Debt/Eq0.32 Sales Q/Q16.34% SMA50-2.07% Rel Volume1.22 Prev Close6.54
Employees10218 LT Debt/Eq0.28 EarningsNov 06 BMO SMA20018.67% Avg Volume2.15M Price6.83
IPOJun 10, 2021 Option/ShortYes / Yes EPS/Sales Surpr.100.00% 1.94% Trades Volume2,629,416 Change4.43%
Date Action Analyst Rating Change Price Target Change
Dec-09-25Initiated Barclays Overweight $8
Nov-13-25Initiated BMO Capital Markets Outperform $8
Jul-25-25Initiated BTIG Research Buy $8
May-27-25Upgrade UBS Neutral → Buy $8.50
Apr-08-25Initiated KeyBanc Capital Markets Overweight $9
Apr-03-25Initiated Canaccord Genuity Buy $8
Dec-16-24Upgrade Goldman Neutral → Buy $10
Jan-03-24Initiated Barclays Underweight $7
May-15-23Downgrade TD Cowen Outperform → Market Perform $8 → $9
Jan-06-23Upgrade Morgan Stanley Equal-Weight → Overweight $8
Feb-02-26 05:20PM
Jan-22-26 02:14PM
Dec-22-25 06:05AM
Dec-11-25 10:33PM
Nov-28-25 09:55AM
11:02PM Loading…
Nov-20-25 11:02PM
Nov-13-25 12:37AM
Nov-12-25 09:55AM
Nov-08-25 05:11AM
Nov-07-25 12:32AM
Nov-06-25 07:15AM
06:12AM
06:00AM
Nov-05-25 09:00AM
07:34AM
10:22PM Loading…
Nov-04-25 10:22PM
Oct-28-25 04:10PM
09:00AM
Oct-16-25 04:10PM
Oct-10-25 03:50PM
Oct-08-25 12:00PM
Sep-26-25 10:21AM
10:09AM
Sep-15-25 11:31PM
Sep-12-25 12:03AM
Sep-10-25 03:11PM
Aug-26-25 04:10PM
Aug-22-25 09:00AM
Aug-17-25 06:20PM
Aug-15-25 11:02AM
01:46PM Loading…
Aug-14-25 01:46PM
01:33AM
Aug-12-25 03:23AM
Aug-11-25 07:45AM
Aug-08-25 02:21PM
Aug-07-25 01:45PM
07:15AM
06:11AM
06:00AM
Aug-05-25 11:08PM
Aug-01-25 06:47AM
12:38AM
Jul-23-25 11:25AM
Jul-22-25 09:00AM
Jul-17-25 04:10PM
Jul-14-25 12:06AM
Jul-11-25 03:30PM
07:17AM
Jul-07-25 09:10AM
Jul-02-25 01:35AM
Jun-27-25 12:00PM
Jun-16-25 09:35AM
Jun-10-25 12:31PM
Jun-05-25 09:55AM
May-28-25 04:10PM
May-27-25 11:35AM
May-25-25 11:31PM
May-14-25 09:00AM
May-08-25 12:00PM
09:35AM
03:14AM
May-07-25 07:10AM
06:00AM
May-06-25 04:05PM
May-05-25 09:55AM
Apr-30-25 10:01AM
Apr-29-25 09:05AM
Apr-22-25 06:12AM
Apr-21-25 04:10PM
Apr-18-25 09:02AM
Apr-16-25 05:11AM
Apr-15-25 09:00AM
Apr-10-25 11:38AM
11:37AM
09:55AM
Mar-21-25 09:55AM
Mar-13-25 05:01AM
Feb-28-25 02:17AM
01:49AM
Feb-27-25 11:13AM
07:35AM
06:20AM
06:02AM
06:00AM
Feb-26-25 08:02AM
07:26AM
Feb-20-25 10:01AM
Feb-06-25 04:10PM
Jan-17-25 12:00PM
Nov-20-24 09:00AM
Nov-08-24 02:14AM
Nov-07-24 07:15AM
06:17AM
06:00AM
Nov-06-24 07:13AM
Oct-17-24 04:10PM
Oct-08-24 09:00AM
Aug-30-24 09:55AM
Aug-27-24 04:45PM
Aug-21-24 04:10PM
Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bessler RobertDirectorDec 19 '25Sale7.04119,942844,3921,318,983Dec 23 07:53 PM
Bessler RobertDirectorDec 22 '25Sale7.041,70111,9751,318,133Dec 23 07:53 PM
Bessler RobertDirectorDec 22 '25Proposed Sale7.041,70111,975Dec 22 04:30 PM
Bessler RobertDirectorDec 18 '25Sale7.006,44245,0941,378,954Dec 19 04:55 PM
Varanakis AnnChief People OfficerDec 17 '25Sale6.9050,000345,000315,610Dec 19 04:49 PM
Bessler RobertDirectorDec 19 '25Proposed Sale7.04119,942844,056Dec 19 04:07 PM
Bessler RobertDirectorDec 18 '25Proposed Sale7.006,44245,113Dec 18 04:02 PM
Varanakis AnnOfficerDec 17 '25Proposed Sale6.9050,000344,843Dec 17 04:13 PM
Bessler RobertDirectorDec 12 '25Sale7.0179,630558,2061,382,175Dec 16 07:49 PM
Bessler RobertDirectorDec 15 '25Sale7.0012,37186,5971,375,989Dec 16 07:49 PM
Bessler RobertDirectorDec 15 '25Proposed Sale7.0012,37186,622Dec 15 04:12 PM
Bessler RobertDirectorDec 12 '25Proposed Sale7.0179,630558,222Dec 12 04:17 PM
Miller Lisa KSee RemarksNov 21 '25Sale6.4357,240368,053261,292Nov 25 04:25 PM
Miller Lisa KOfficerNov 21 '25Proposed Sale6.4357,240368,143Nov 21 04:38 PM
Silversmith Partners I GP, LLCMember of 10% GroupAug 18 '25Sale5.073,592,35718,213,25014,324,197Aug 20 04:49 PM
BLACK DARREN M.DirectorAug 18 '25Sale5.078,407,64342,626,75033,524,715Aug 20 04:47 PM
SUMMIT PARTNERS L P10% OwnerAug 18 '25Sale5.078,407,64342,626,75033,524,715Aug 20 04:34 PM
Silversmith Capital Partners IShareholderAug 18 '25Proposed Sale5.41894,0984,837,070Aug 18 08:42 PM
Silversmith Capital Partners IShareholderAug 18 '25Proposed Sale5.412,471,74113,372,119Aug 18 08:41 PM
Silversmith Capital Partners IShareholderAug 18 '25Proposed Sale5.41226,5181,225,462Aug 18 08:39 PM
SUMMIT PARTNERS GROWTH EQUITY OwnerAug 18 '25Proposed Sale5.413,214,64817,391,246Aug 18 08:37 PM
SUMMIT PARTNERS GROWTH EQUITY OwnerAug 18 '25Proposed Sale5.415,148,49427,853,353Aug 18 08:36 PM
SUMMIT PARTNERS ENTREPRENEUR AOwnerAug 18 '25Proposed Sale5.414,80425,990Aug 18 08:34 PM
SUMMIT INVESTORS GE IX-VC IV, OwnerAug 18 '25Proposed Sale5.4135,938194,425Aug 18 08:32 PM
SUMMIT INVESTORS GE IX/VC IV (OwnerAug 18 '25Proposed Sale5.413,75920,336Aug 18 08:30 PM
Burdick Kenneth ADirectorAug 08 '25Buy4.3647,670207,7513,416,571Aug 12 04:30 PM
Burdick Kenneth ADirectorAug 08 '25Buy4.3046,511199,99746,511Aug 12 04:30 PM
Burdick Kenneth ADirectorAug 11 '25Buy4.5320,00090,5453,436,571Aug 12 04:30 PM
Ramtekkar UjjwalChief Medical OfficerJun 16 '25Sale5.179,51949,213103,916Jun 18 04:00 PM
Ramtekkar UjjwalOfficerJun 16 '25Proposed Sale5.179,51949,213Jun 16 04:09 PM
Ramtekkar UjjwalChief Medical OfficerJun 05 '25Sale5.9416,00095,040113,435Jun 09 05:00 PM
Ramtekkar UjjwalOfficerJun 05 '25Proposed Sale5.9416,00094,961Jun 05 04:45 PM
Bessler RobertDirectorApr 09 '25Sale7.014,90034,3491,421,990Apr 10 04:30 PM
Bessler RobertDirectorApr 08 '25Sale7.0014981,424,440Apr 10 04:30 PM
Bessler RobertDirectorApr 09 '25Proposed Sale7.014,90034,338Apr 09 04:07 PM
Bessler RobertDirectorApr 08 '25Proposed Sale7.001498Apr 08 04:15 PM
Miller Lisa KSee RemarksMar 17 '25Sale6.9018,845130,030339,810Mar 18 07:29 PM
Miller Lisa KOfficerMar 17 '25Proposed Sale6.9018,845129,993Mar 17 04:05 PM
Pantaleoni PabloChief Digital OfficerMar 07 '25Sale7.2919,900145,071538,185Mar 12 04:13 PM
Pantaleoni PabloChief Digital OfficerMar 10 '25Sale7.6415,605119,222522,580Mar 12 04:13 PM
PANTALEONI-ZUAZU TRUSTOfficerMar 10 '25Proposed Sale7.5959,700453,123Mar 10 04:14 PM
PANTALEONI-ZUAZU TRUSTOfficerMar 07 '25Proposed Sale7.6419,900152,062Mar 07 04:40 PM